These studies support the role of P2X7 receptor antagonists in treating epilepsy, including drug-resistant epilepsy (Beamer et al., 2016; Cieslak et al., 2017; Rodriguez-Alvarez et al., 2017). This evidence concerns the gene P2RX7 and epilepsy.